Literature DB >> 9826222

Urinary endothelin in adolescents and young adults with insulin-dependent diabetes mellitus: relation to urinary albumin, blood pressure, and other factors.

M Peppa-Patrikiou1, M Dracopoulou, C Dacou-Voutetakis.   

Abstract

Endothelin (ET) is a potent vasoconstrictive peptide that may play a role in vascular pathology in general and diabetic nephropathy in particular. The aim of this study was to investigate (1) alterations of urinary ET1 (UET1) in adolescents and young adults with insulin-dependent diabetes mellitus (IDDM) and (2) the relation of UET1 to other indices of diabetic nephropathy and to risk factors of diabetic angiopathy in general. In 130 IDDM subjects aged 15.2+/-4.9 years with a diabetes duration of 7.3+/-5.1 years, UET1 by radioimmunoassay, urinary albumin by nephelometry, plasma renin by immunoradiometric assay, hemoglobin A1c (HbA1c) by high-performance liquid chromatography, and routine biochemistry analyses were determined. Forty-eight controls, healthy siblings of the diabetics of comparable age, were similarly studied. Total 24-hour UET1 excretion was higher in diabetics than in controls (10,866+/-7,270 and 6,598+/-3,294 pg/24 h, respectively, P=.000). This difference was also noted if male and female diabetics were separately compared with controls. In diabetics with normoalbuminuria (<20 microg/min), total 24-hour UET1 excretion was also higher than in controls (P=.002). In diabetics but not in controls, 24-hour UET1 values were higher in males than in females (P=.018). In IDDM subjects, UET1 showed a linear relationship with age (P=.002), urinary albumin (P=.000), serum creatinine (P=.001), systolic blood pressure (P=.038), triglycerides (P=.003), and HbA1c (P=.041). Multiple regression analysis demonstrated that the variables interacting independently with UET1 were urinary albumin (P=.003) and serum creatinine (P=.038). UET1 is elevated early (in adolescence) in IDDM subjects, and it is positively correlated with the degree of albuminuria. These data suggest that the amount of UET1 possibly reflects the severity of diabetic renovascular damage. It may thus be speculated that UET1 could be used as another index of diabetic nephropathy or its progress.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826222     DOI: 10.1016/s0026-0495(98)90314-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice.

Authors:  Malgorzata Kasztan; Brandon M Fox; Joshua S Speed; Carmen De Miguel; Eman Y Gohar; Tim M Townes; Abdullah Kutlar; Jennifer S Pollock; David M Pollock
Journal:  J Am Soc Nephrol       Date:  2017-03-27       Impact factor: 10.121

2.  Renal hyperfiltration related to diabetes mellitus and obesity in human disease.

Authors:  Alexa N Sasson; David Zi Cherney
Journal:  World J Diabetes       Date:  2012-01-15

3.  Avosentan reduces albumin excretion in diabetics with macroalbuminuria.

Authors:  René R Wenzel; Thomas Littke; Susan Kuranoff; Christiane Jürgens; Heike Bruck; Eberhard Ritz; Thomas Philipp; Anna Mitchell
Journal:  J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 10.121

4.  Enhanced vascular chymase-dependent conversion of endothelin in the diabetic kidney.

Authors:  Lisa M Harrison-Bernard; Lawrence de Garavilla; Benjamin J Bivona
Journal:  Ochsner J       Date:  2013

5.  Urinary excretion of endothelin-1 in children with absorptive idiopathic hypercalciuria.

Authors:  Polyxeni Nicolaidou; Helen Georgouli; Vasiliki Getsi; Helen Tsapra; Fotini Psychou; Yiannis G Matsinos; Petros M Zeis; Dimitris Gourgiotis
Journal:  Pediatr Nephrol       Date:  2003-10-02       Impact factor: 3.714

6.  TRC120038, a Novel Dual AT(1)/ET(A) Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats.

Authors:  Anookh Mohanan; Ram Gupta; Amita Dubey; Vikrant Jagtap; Appaji Mandhare; Ramesh C Gupta; Vijay Chauthaiwale; Chaitanya Dutt
Journal:  Int J Hypertens       Date:  2011-12-22       Impact factor: 2.420

Review 7.  Circulatory syndrome: an evolution of the metabolic syndrome concept!

Authors:  Ali Reza Khoshdel; Shane L Carney; Alastair Gillies
Journal:  Curr Cardiol Rev       Date:  2012-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.